BUY
Numbers beat street expectations. The market concern is that butterfat pricing will cut into their margins, but he feels the company has a lot of leeway to generate growth. The drop is a buying opportunity.
DON'T BUY
Expected to lose $.90 a share in the forward 12 months. Even if they have a turnaround, they will need more cash. Wait for a solid turnaround.
DON'T BUY
Have had three quarters profits in a role. Would prefer more niche oriented focused telecom equipment companies or Cisco or Nortel once because clear.
DON'T BUY
The clouds on the stock are pretty thick because of the FCC/OSC issues.
BUY
They more than replace the production and they don't payout 100% of their cash flow. A great energy trust. The one risk is gas pricing because the company continues to be largely unhedged.
BUY
Earnings are to be reported in early May and there are rumors that they'll miss their numbers and will take write-downs but he doesn't believe either is correct. A cheap stock and their financials will generate a lot of cash over the next few years.
STRONG BUY
An excellent long-term buy and hold. India remains the one last large unexplored territory for gas/oil reserves.
HOLD
Has had a great run over the last year. The valuation looks relatively inexpensive, but is not as cheap as it might appear. The big fear is that a Las Vegas outfit might deliver a big mousetrap.
PAST TOP PICK
(A top pick Jan 26/04. Up 9.7%.) Continues to be a previously underperforming gold company that has shown signs of changing for the better.
PAST TOP PICK
(A top pick Jan 26/04. Down 17%.) Was a trading buy and got out when the price went up. Wouldn't buy today.
PAST TOP PICK
(A top pick Jan 26/04. Up 5%.) Continues to be a well-managed steady Eddie. Continues to like.
BUY
Continues to like this stock. Expect them to get rid of the 13% coupon debt. Also expects further consolidation in the media industry in Canada and this could be a takeover.
DON'T BUY
Has had a big run and expects it to pause here for a little while. Have a lot of cash. Fully valued.
DON'T BUY
Medical device companies are a bit of a minefield because big boys like Abbott, Baxter, Johnson & Johnson control the purchasing through a hospital. Interesting technology. Using a lot of cash. Wait to see their numbers. A high risk situation.
HOLD
At a point in the trading cycle where banks are a little more out of favor than insurance companies.